Transmembrane signaling through CD80 (B7-1) induces growth arrest and cell spreading of human B lymphocytes accompanied by protein tyrosine phosphorylation

被引:27
|
作者
Hirokawa, M
Kuroki, J
Kitabayashi, A
Miura, AB
机构
[1] Division of Hematology, Department of Internal Medicine III, Akita University School of Medicine, Akita 010
关键词
CD80; B lymphocyte; transmembrane signaling; protein tyrosine phosphorylation;
D O I
10.1016/0165-2478(96)02526-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We addressed the issue of the role for CD80 (B7-1) expressed on human B cells in transmembrane signaling. Cross-linking of CD80 on B lymphoma Raji cells induced tyrosine phosphorylation in 160-, 120-, 55-, 46- and 44-kDa proteins, which was inhibited by genistein. CD80-mediated signaling resulted in the inhibition of DNA replication of B cells and induced the changes in morphology like macrophages or fibroblasts. This cell spreading was inhibited by the pre-treatment of the cells with genistein. These results suggest that the CD80 antigen is involved in transmembrane outside-in signaling in B cells and its biological effects appear to be mediated by tyrosine kinases.
引用
收藏
页码:95 / 98
页数:4
相关论文
共 50 条
  • [31] Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2)
    Morton, PA
    Fu, XT
    Stewart, JA
    Giacoletto, KS
    White, SL
    Leysath, CE
    Evans, RJ
    Shieh, JJ
    Karr, RW
    JOURNAL OF IMMUNOLOGY, 1996, 156 (03): : 1047 - 1054
  • [32] Expression of B7-1 (CD80) and B7-2 (CD86) molecules by human brain endothelial cells in vitro.
    Omari, K
    Prameva, R
    DoroviniZis, K
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (05): : 19 - 19
  • [33] Th 1 and Th 2 cytokines differentially regulate CD80 (B7-1) and CD86 (B7-2) impression and function on human Langerhans cell
    Yokozeki, H
    Matsunaga, T
    Satoh, T
    Katayama, I
    Azuma, M
    Okumura, K
    Nishioka, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 439 - 439
  • [34] The role of CD80 (B7-1) costimulatory molecule in chronic allograft rejection.
    Denton, MD
    Knoflach, A
    Chandraker, A
    Sayegh, MH
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3055 - A3055
  • [35] Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma
    Tirapu, I
    Huarte, E
    Guiducci, C
    Arina, A
    Zaratiegui, M
    Murillo, O
    Gonzalez, A
    Berasain, C
    Berraondo, P
    Fortes, P
    Prieto, J
    Colombo, MP
    Chen, LP
    Melero, I
    CANCER RESEARCH, 2006, 66 (04) : 2442 - 2450
  • [36] Glycosylation is not required for B7-1(CD80) association with its counter-receptors.
    Chen, AS
    Meyerson, H
    Tykocinski, AM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 839 - 839
  • [37] Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma
    Tirapu, Inigo
    Arina, Ainhoa
    Murillo, Oihana
    Fortes, Puri
    Guiducci, Cristiana
    Colombo, Mario P.
    Chen, Lieping
    Melero, Ignacio
    CANCER RESEARCH, 2006, 66 (08)
  • [38] Differential involvement of CD80 (B7-1) and CD86 (B7-2) in allogeneic tumor rejection.
    Prell, RA
    Kerkvliet, NI
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 164 - 164
  • [39] Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis
    Sellebjerg, F
    Jensen, J
    Ryder, LP
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 84 (02) : 179 - 187
  • [40] Detection of a soluble form of B7-1 (CD80) in synovial fluid from patients with arthritis using monoclonal antibodies against distinct epitopes of human B7-1
    McHugh, RS
    Ratnoff, WD
    Gilmartin, R
    Sell, KW
    Selvaraj, P
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 87 (01): : 50 - 59